| Hippocampal avoidance during whole-brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001 PD Brown, V Gondi, S Pugh, WA Tome, JS Wefel, TS Armstrong, JA Bovi, ... Journal of Clinical Oncology 38 (10), 1019-1029, 2020 | 618 | 2020 |
| Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539 L Rogers, P Zhang, MA Vogelbaum, A Perry, LS Ashby, JM Modi, ... Journal of neurosurgery 129 (1), 35-47, 2017 | 252 | 2017 |
| Phase I and II study of induction chemotherapy with methotrexate, rituximab, and temozolomide, followed by whole-brain radiotherapy and postirradiation temozolomide for primary … J Glass, M Won, CJ Schultz, D Brat, NL Bartlett, JH Suh, M Werner-Wasik, ... Journal of Clinical Oncology 34 (14), 1620, 2016 | 145 | 2016 |
| Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539 CL Rogers, A Perry, S Pugh, MA Vogelbaum, D Brachman, W McMillan, ... Neuro-oncology 18 (4), 565-574, 2015 | 128 | 2015 |
| Precise ex vivo histological validation of heightened cellularity and diffusion-restricted necrosis in regions of dark apparent diffusion coefficient in 7 cases of high-grade … PS LaViolette, NJ Mickevicius, EJ Cochran, SD Rand, J Connelly, JA Bovi, ... Neuro-oncology 16 (12), 1599-1606, 2014 | 99 | 2014 |
| Progressing bevacizumab-induced diffusion restriction is associated with coagulative necrosis surrounded by viable tumor and decreased overall survival in patients with … HS Nguyen, N Milbach, SL Hurrell, E Cochran, J Connelly, JA Bovi, ... American Journal of Neuroradiology 37 (12), 2201-2208, 2016 | 78 | 2016 |
| NRG brain tumor specialists consensus guidelines for glioblastoma contouring TJ Kruser, WR Bosch, SN Badiyan, JA Bovi, AJ Ghia, MM Kim, AA Solanki, ... Journal of neuro-oncology 143, 157-166, 2019 | 75 | 2019 |
| Comparison of three accelerated partial breast irradiation techniques: treatment effectiveness based upon biological models J Bovi, XS Qi, J White, XA Li Radiotherapy and Oncology 84 (3), 226-232, 2007 | 75 | 2007 |
| Current management of primary central nervous system lymphoma CJ Schultz, J Bovi International Journal of Radiation Oncology* Biology* Physics 76 (3), 666-678, 2010 | 62 | 2010 |
| Preservation of neurocognitive function (NCF) with conformal avoidance of the hippocampus during whole-brain radiotherapy (HA-WBRT) for brain metastases: preliminary results of … V Gondi, S Deshmukh, PD Brown, JS Wefel, WA Tome, DW Bruner, ... International Journal of Radiation Oncology, Biology, Physics 102 (5), 1607, 2018 | 61 | 2018 |
| Gamma knife surgery of vestibular schwannomas: volumetric dosimetry correlations to hearing loss suggest stria vascularis devascularization as the mechanism of early hearing loss PA Wackym, CL Runge-Samuelson, JJ Nash, DM Poetker, K Albano, ... Otology & Neurotology 31 (9), 1480-1487, 2010 | 49 | 2010 |
| Multidisciplinary patient-centered management of brain metastases and future directions JD Palmer, DM Trifiletti, V Gondi, M Chan, G Minniti, CG Rusthoven, ... Neuro-Oncology Advances 2 (1), vdaa034, 2020 | 45 | 2020 |
| NRG Oncology CC001: A phase III trial of hippocampal avoidance (HA) in addition to whole-brain radiotherapy (WBRT) plus memantine to preserve neurocognitive function (NCF) in … V Gondi, S Deshmukh, PD Brown, JS Wefel, W Tome, T Armstrong, ... Journal of Clinical Oncology 37 (15_suppl), 2009-2009, 2019 | 41 | 2019 |
| Evaluation of absolute and normalized apparent diffusion coefficient (ADC) values within the post-operative T2/FLAIR volume as adverse prognostic indicators in glioblastoma A Elson, J Bovi, M Siker, C Schultz, E Paulson Journal of neuro-oncology 122, 549-558, 2015 | 41 | 2015 |
| Phase 2 study of a temozolomide-based chemoradiation therapy regimen for high-risk, low-grade gliomas: long-term results of radiation therapy oncology group 0424 BJ Fisher, SL Pugh, DR Macdonald, A Chakravatri, GJ Lesser, S Fox, ... International Journal of Radiation Oncology* Biology* Physics 107 (4), 720-725, 2020 | 38 | 2020 |
| Dose escalated radiation therapy for glioblastoma multiforme: an international systematic review and meta-analysis of 22 prospective trials R Singh, EJ Lehrer, M Wang, HK Perlow, NG Zaorsky, DM Trifiletti, J Bovi, ... International Journal of Radiation Oncology* Biology* Physics 111 (2), 371-384, 2021 | 36 | 2021 |
| Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for … AMP Omuro, LM DeAngelis, T Karrison, JA Bovi, M Rosenblum, BW Corn, ... Journal of Clinical Oncology 38 (15_suppl), 2501-2501, 2020 | 35 | 2020 |
| Postirradiation morphea in a breast cancer patient S Dubner, J Bovi, J White, B Susnik The Breast Journal 12 (2), 173-176, 2006 | 35 | 2006 |
| Glioma consensus contouring recommendations from a MR-Linac International Consortium Research Group and evaluation of a CT-MRI and MRI-only workflow CL Tseng, J Stewart, G Whitfield, JJC Verhoeff, J Bovi, H Soliman, ... Journal of neuro-oncology 149, 305-314, 2020 | 34 | 2020 |
| Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513 DG Brachman, SL Pugh, LS Ashby, TA Thomas, EM Dunbar, S Narayan, ... International Journal of Radiation Oncology* Biology* Physics 91 (5), 961-967, 2015 | 32 | 2015 |
